Advagraf

Advagraf, containing tacrolimus, is an immunosuppressant used to prevent organ rejection post-transplant. It helps maintain immune system balance for transplant recipients.

Advagraf is primarily used to prevent rejection of transplanted organs, such as kidneys, liver, or heart. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. Tacrolimus, the active ingredient, is often prescribed for long-term use in transplant patients.

Common effects of Advagraf may include tremors, headaches, and increased blood pressure. Some users also report gastrointestinal issues like nausea or diarrhea. These effects can vary widely among individuals.

Advagraf should be handled with care, as it can increase the risk of infections due to its immune-suppressing properties. Regular monitoring by a healthcare provider is essential. Avoid grapefruit and grapefruit juice, as they can affect how the body processes tacrolimus.

Advagraf may interact with various medications, including certain antibiotics, antifungals, and heart medications. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be consumed with caution.